Soedjatmiko Soedjatmiko

Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia
Jakarta, JK, Indonesia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 study.

Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 study.

Journal: Human vaccines & immunotherapeutics

Published: December 05, 2024

Immunization Simulation Using Actual-Size Infant Manikins for Medical Students in Indonesia: A Quasi-Experimental Study.

Immunization Simulation Using Actual-Size Infant Manikins for Medical Students in Indonesia: A Quasi-Experimental Study.

Journal: Simulation in healthcare : journal of the Society for Simulation in Healthcare

Published: February 08, 2024

Educational videos to address vaccine hesitancy in childhood immunization.

Educational videos to address vaccine hesitancy in childhood immunization.

Journal: Vaccine

Published: June 21, 2022

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report.

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report.

Journal: BMC pediatrics

Published: July 15, 2020

One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine.

One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: November 15, 2019

Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major.

Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major.

Journal: Blood cells, molecules & diseases

Published: December 12, 2018

Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.

Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.

Journal: PloS one

Published: May 30, 2018

Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children.

Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children.

Journal: PLoS neglected tropical diseases

Published: May 03, 2018

Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children.

Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children.

Journal: Vaccine

Published: August 24, 2017

Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children.

Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children.

Journal: PLoS neglected tropical diseases

Published: January 02, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026